Document is current
Any future updates will be listed below
-
Authors
Cao, Jiawei https://orcid.org/0000-0001-6268-5912
Wu, Tao
Zhou, Tong
Jiang, Zewei
Ren, Yinrui
Yu, Jiawei
Wang, Jiayi
Qian, Changrui
Wu, Guang
He, Licai
Li, Hongzhi
Lin, Rixu https://orcid.org/0000-0003-2498-8116
Liu, Min https://orcid.org/0000-0002-3280-472X
Gu, Haihua https://orcid.org/0000-0003-2154-9900
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Zhejiang Province (LZ23H160001)
Natural Science Foundation of Zhejiang Province (LQ23H160012)
National Natural Science Foundation of China (82302925)
National Natural Science Foundation of China (82272702)
National Natural Science Foundation of China (LTGY23H080005)
Medical and Health Science and Technology Plan Project of Zhejiang Province,China
- License Information
-
More Information
Article History
Received: 15 June 2024
Accepted: 10 January 2025
First Online: 16 January 2025
Competing interests
: The authors declare no competing interests.
: All human breast tumor samples were obtained from patients with informed consent. The current study (protocol# 2019006) was approved by the Institutional Review Board for human study of Wenzhou Medical University and conducted according to the principles expressed in the Helsinki Declaration. The animal study (protocol# wydw2023-0484) was approved by the Institutional Animal Care and Use Committee of Wenzhou Medical University and conducted in compliance with relevant local guidelines.
